Tonix Pharmaceuticals (TNXP) Earnings Date, Estimates & Call Transcripts $46.49 -0.43 (-0.92%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$46.30 -0.19 (-0.40%) As of 08/8/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tonix Pharmaceuticals Earnings Summary Tonix Pharmaceuticals posted Q1 2025 earnings on May 12, 2025, reporting an EPS of -$2.84, which topped analysts' consensus estimates of -$3.23 by $0.39. Quarterly revenue was reported to be $2.43 million, below the consensus estimate of $2.55 million. With a trailing EPS of -$1,963.61, Tonix Pharmaceuticals' earnings are expected to grow next year, from ($1,762.50) to ($541.50) per share. Upcoming Q2 Earnings DateAug. 15Before Market OpensEstimatedConsensus EPS (May. 12) -$3.23 Actual EPS (May. 12) -$2.84 Beat By $0.39 Actual Revenue (May. 12) $2.43MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)TNXP Upcoming EarningsTonix Pharmaceuticals' Q1 2025 earnings is scheduled for Friday, August 15, 2025Powered by Get Tonix Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tonix Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTNXP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TNXP Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Tonix Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$3.37-$3.37-$3.37Q2 20251-$3.51-$3.51-$3.51Q3 20251-$3.24-$3.24-$3.24Q4 20251-$3.91-$3.91-$3.91 Tonix Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/15/2025(Estimated)--------5/12/2025Q1 2025-$3.23-$2.84+$0.39-$2.84$2.55M$2.43M3/18/2025Q4 2024-$6.23-$9.77 -$3.54-$9.77$3.20M$2.58M11/12/2024--$203.00-$23.00+$180.00-$0.23$2.63M$2.82M8/16/2024--$991.00-$1,928.00 -$937.00-$19.28$3.50M$2.21M5/13/2024Q1 2024-$1,664.00-$576.00+$1,088.00-$0.18$4.00M$2.48M4/1/2024Q4 2023--$2,752.00--$0.86$3.95M$3.78M11/9/2023Q3 2023-$4,768.00-$5,856.00 -$1,088.00-$1.83$5.80M$3.99M8/10/2023Q2 2023-$8,896.00-$8,576.00+$320.00-$2.68-- Tonix Pharmaceuticals Earnings - Frequently Asked Questions When is Tonix Pharmaceuticals' earnings date? Tonix Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 15th, 2025 based off last year's report dates. Learn more on TNXP's earnings history. Did Tonix Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Tonix Pharmaceuticals (NASDAQ:TNXP) reported ($2.84) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.23) by $0.39. Learn more on analysts' earnings estimate vs. TNXP's actual earnings. How much revenue does Tonix Pharmaceuticals generate each year? Tonix Pharmaceuticals (NASDAQ:TNXP) has a recorded annual revenue of $10.09 million. How much profit does Tonix Pharmaceuticals generate each year? Tonix Pharmaceuticals (NASDAQ:TNXP) has a recorded net income of -$130.04 million. TNXP has generated -$1,963.61 earnings per share over the last four quarters. What is Tonix Pharmaceuticals' EPS forecast for next year? Tonix Pharmaceuticals' earnings are expected to grow from ($1,762.50) per share to ($541.50) per share in the next year. More Earnings Resources from MarketBeat Related Companies HROW Earnings PRAX Earnings PAHC Earnings AVDL Earnings SYRE Earnings GPCR Earnings PHVS Earnings VERV Earnings AMPH Earnings ARDX Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Airbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a Rally This page (NASDAQ:TNXP) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
